SuperworthEvommune shares outstanding EVMN
Diluted shares outstanding, averaged over each quarter, from 2024.
- Latest quarter, to Jun 30, 2026
- 36.1M
- On a year earlier
- +2245.4%
- more shares
Evommune had 36.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2245.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2024 | 1.5M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 36.1M | +2245% | |
| Q1 FY26 | 33.7M | +2094% | |
| Q3 FY25 | 1.5M | +2% | |
| Q2 FY25 | 1.5M | n/a | |
| Q1 FY25 | 1.5M | n/a | |
| Q4 FY24 | 1.5M | n/a | |
| Q3 FY24 | 1.5M | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Evommune
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.